526 related articles for article (PubMed ID: 15663989)
21. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
[TBL] [Abstract][Full Text] [Related]
22. Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins.
Ma H; Hong H; Huang SM; Irvine RA; Webb P; Kushner PJ; Coetzee GA; Stallcup MR
Mol Cell Biol; 1999 Sep; 19(9):6164-73. PubMed ID: 10454563
[TBL] [Abstract][Full Text] [Related]
23. Thyroid receptor activator molecule, TRAM-1, is an androgen receptor coactivator.
Tan JA; Hall SH; Petrusz P; French FS
Endocrinology; 2000 Sep; 141(9):3440-50. PubMed ID: 10965917
[TBL] [Abstract][Full Text] [Related]
24. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
Yoon HG; Wong J
Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
[TBL] [Abstract][Full Text] [Related]
25. Different expression of androgen receptor coactivators in human prostate.
Fujimoto N; Mizokami A; Harada S; Matsumoto T
Urology; 2001 Aug; 58(2):289-94. PubMed ID: 11489729
[TBL] [Abstract][Full Text] [Related]
26. Recognition and accommodation at the androgen receptor coactivator binding interface.
Hur E; Pfaff SJ; Payne ES; Grøn H; Buehrer BM; Fletterick RJ
PLoS Biol; 2004 Sep; 2(9):E274. PubMed ID: 15328534
[TBL] [Abstract][Full Text] [Related]
27. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
Kang Z; Jänne OA; Palvimo JJ
Mol Endocrinol; 2004 Nov; 18(11):2633-48. PubMed ID: 15308689
[TBL] [Abstract][Full Text] [Related]
28. Endogenous coactivator ARA70 interacts with estrogen receptor alpha (ERalpha) and modulates the functional ERalpha/androgen receptor interplay in MCF-7 cells.
Lanzino M; De Amicis F; McPhaul MJ; Marsico S; Panno ML; Andò S
J Biol Chem; 2005 May; 280(21):20421-30. PubMed ID: 15772083
[TBL] [Abstract][Full Text] [Related]
29. Role of p160 coactivator complex in the activation of liver X receptor.
Huuskonen J; Fielding PE; Fielding CJ
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):703-8. PubMed ID: 14764426
[TBL] [Abstract][Full Text] [Related]
30. Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells.
Shi XB; Xue L; Zou JX; Gandour-Edwards R; Chen H; deVere White RW
Prostate; 2008 Dec; 68(16):1816-26. PubMed ID: 18780293
[TBL] [Abstract][Full Text] [Related]
31. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells.
Yeh S; Chang C
Proc Natl Acad Sci U S A; 1996 May; 93(11):5517-21. PubMed ID: 8643607
[TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor-alpha interaction with the CREB binding protein coactivator is regulated by the cellular environment.
Jaber BM; Mukopadhyay R; Smith CL
J Mol Endocrinol; 2004 Feb; 32(1):307-23. PubMed ID: 14766010
[TBL] [Abstract][Full Text] [Related]
33. A regulatory role for RIP140 in nuclear receptor activation.
Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
[TBL] [Abstract][Full Text] [Related]
34. Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer.
Heemers HV; Regan KM; Dehm SM; Tindall DJ
Cancer Res; 2007 Nov; 67(21):10592-9. PubMed ID: 17975004
[TBL] [Abstract][Full Text] [Related]
35. Subcellular localization of the steroid receptor coactivators (SRCs) and MEF2 in muscle and rhabdomyosarcoma cells.
Chen SL; Wang SC; Hosking B; Muscat GE
Mol Endocrinol; 2001 May; 15(5):783-96. PubMed ID: 11328858
[TBL] [Abstract][Full Text] [Related]
36. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
Hodgson MC; Astapova I; Hollenberg AN; Balk SP
Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells.
Mitchell SH; Zhu W; Young CY
Cancer Res; 1999 Dec; 59(23):5892-5. PubMed ID: 10606230
[TBL] [Abstract][Full Text] [Related]
38. From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells.
Yeh S; Lin HK; Kang HY; Thin TH; Lin MF; Chang C
Proc Natl Acad Sci U S A; 1999 May; 96(10):5458-63. PubMed ID: 10318905
[TBL] [Abstract][Full Text] [Related]
39. Androgen axis in prostate cancer.
Culig Z; Bartsch G
J Cell Biochem; 2006 Oct; 99(2):373-81. PubMed ID: 16598769
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of the androgen receptor and its coactivators in patients with D1 prostate cancer.
Mori R; Wang Q; Quek ML; Tarabolous C; Cheung E; Ye W; Groshen S; Hawes D; Togo S; Shimada H; Danenberg KD; Danenberg PV; Pinski JK
Anticancer Res; 2008; 28(1B):425-30. PubMed ID: 18383880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]